Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Barber, Alison G ^a   Castillo Martin, Mireia ^d   Bonal, Dennis M ^d   Rybicki, Benjamin A ^c   Christiano, Angela M ^a   Cordon Cardo, Carlos ^a,b,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Department of Medicine   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN; DESMOGLEIN 1; DESMOGLEIN 2; DESMOGLEIN 3; DESMOGLEIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL; CANCER CELL LINE; CANCER RECURRENCE; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE MICROARRAY; CANCER GRADING; CANCER STAGING; DISEASE COURSE; FOLLOW UP; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; COHORT STUDIES; DESMOGLEIN 2; DESMOGLEINS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84902492626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098786     Document Type: Article

References (43)

1. Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, et al (1999) N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet 8: 971-976. (Pubitemid 29250884)
2. Barber AG, Wajid M, Columbo M, Lubetkin J, Christiano AM (2007) Striate palmoplantar keratoderma resulting from a frameshift mutation in the desmoglein 1 gene. J Dermatol Sci 45: 161-166. (Pubitemid 46216049)
3. Awad MM, Dalal D, Cho E, Amat-Alarcon N, James C, et al (2006) DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Am J Hum Genet 79: 136-142. (Pubitemid 43927384)
4. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, et al (2006) Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113: 1171-1179.
5. Syrris P, Ward D, Asimaki A, Evans A, Sen-Chowdhry S, et al (2007) Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease. Eur Heart J 28: 581-588. (Pubitemid 47355498)
6. Heuser A, Plovie ER, Ellinor PT, Grossmann KS, Shin JT, et al (2006) Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 79: 1081-1088. (Pubitemid 44853479)
7. Simpson MA, Mansour S, Ahnood D, Kalidas K, Patton MA, et al (2009) Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology 113: 28-34.
8. Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaughnessy R, et al (2003) Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113: 249-260. (Pubitemid 36514975)
9. Schweizer J (2006) More than one gene involved in monilethrix: intracellular but also extracellular players. J Invest Dermatol 126: 1216-1219.
10. Shimomura Y, Sakamoto F, Kariya N, Matsunaga K, Ito M (2006) Mutations in the desmoglein 4 gene are associated with monilethrix-like congenital hypotrichosis. J Invest Dermatol 126: 1281-1285. (Pubitemid 43997908)
11. Zlotogorski A, Marek D, Horev L, Abu A, Ben-Amitai D, et al (2006) An autosomal recessive form of monilethrix is caused by mutations in DSG4: clinical overlap with localized autosomal recessive hypotrichosis. J Invest Dermatol 126: 1292-1296. (Pubitemid 43997910)
12. Schaffer JV, Bazzi H, Vitebsky A, Witkiewicz A, Kovich OI, et al (2006) Mutations in the desmoglein 4 gene underlie localized autosomal recessive hypotrichosis with monilethrix hairs and congenital scalp erosions. J Invest Dermatol 126: 1286-1291. (Pubitemid 43997909)
13. Amagai M (1999) Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20: 92-102.
14. Getsios S, Huen AC, Green KJ (2004) Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 5: 271-281. (Pubitemid 38480608)
15. Tselepis C, Chidgey M, North A, Garrod D (1998) Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A 95: 8064-8069. (Pubitemid 28326066)
16. Delva E, Tucker DK, Kowalczyk AP (2009) The desmosome. Cold Spring Harb Perspect Biol 1: a002543.
17. Karkera JD, Ayache S, Ransome RJ, Jr. Jackson MA, Elsayem AF, et al (2000) Refinement of regions with allelic loss on chromosome 18p11.2 and 18q12.2 in esophageal squamous cell carcinoma. Clin Cancer Res 6: 3565-3569.
18. Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, et al (2000) Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 60: 3397-3403. (Pubitemid 30482154)
19. Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, et al (2005) Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 207: 199-206. (Pubitemid 41404150)
20. Yashiro M, Nishioka N, Hirakawa K (2006) Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42: 2397-2403. (Pubitemid 44307618)
21. Ramani VC, Hennings L, Haun RS (2008) Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 8: 373.
22. Kurzen H, Munzing I, Hartschuh W (2003) Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30: 621-630. (Pubitemid 37372350)
23. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, et al (2007) DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26: 467-476. (Pubitemid 46122837)
24. Schafer S, Stumpp S, Franke WW (1996) Immunological identification and characterization of the desmosomal cadherin Dsg2 in coupled and uncoupled epithelial cells and in human tissues. Differentiation 60: 99-108. (Pubitemid 26150789)
25. Whittock NV, Bower C (2003) Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 120: 523-530. (Pubitemid 36343993)
26. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, et al (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32: 690-697. (Pubitemid 32726893)
27. Berx G, van Roy F (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1: a003129.
28. Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, et al (2005) Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 25: 183-91. (Pubitemid 40470109)
29. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, et al (2002) Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-63.
30. Davies G, Jiang WG, Mason MD (2000) Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J Urol 163: 985-92. (Pubitemid 30091675)
31. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, et al (2006) Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 30: 412-422. (Pubitemid 44750413)
32. Bazzi H, Getz A, Mahoney MG, Ishida-Yamamoto A, Langbein L, et al (2006) Desmoglein 4 is expressed in highly differentiated keratinocytes and trichocytes in human epidermis and hair follicle. Differentiation 74: 129-140. (Pubitemid 43376172)
33. Wahl III JK (2002) Generation of monoclonal antibodies specific for desmoglein family members. Hybrid Hybridomics 21: 37-44.
34. Karni-Schmidt O, Castillo-Martin M, Shen TH, Gladoun N, Domingo-Domenech J, et al (2011) Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol 178: 1350-60.
35. Domingo-Domenech J, Oliva C, Rovira A, Codony-Servat J, Bosch M, et al (2006) Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res 15: 5578-86. (Pubitemid 44497276)
36. Abate-Shen C, Shen MM (2000) Molecular genetics of prostate cancer. Genes Dev 14: 2410-2434.
37. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98-106. (Pubitemid 26066247)
38. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, et al (1980) The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132.
39. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23. (Pubitemid 9239413)
40. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281. (Pubitemid 8283045)
41. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, et al (1995) Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 31: 14-24.
42. Lang SH, Sharrard RM, Stark M, Villette JM, Maitland NJ (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 85: 590-599. (Pubitemid 32808286)
43. Baron S, Hoang A, Vogel H, Attardi LD (2012) Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice. PLoS One 7: e50024.